Copiously shedding data in the form of novel proteins in his sweat, Chester Inkley entered the public atrium of Megablast Microbiomics in a panic. The first person to see him, an attractive young receptionist named SueEllen Glanders, remained remarkably self-composed at his alarming, wild-eyed appearance. Her professional sangfroid could be attributed to the fact that Inkley was the fourth person exhibiting these symptoms to arrive at Megablast Microbiomics in the past few hours. In truth, she had been highly flustered when the first irrational victim showed up. But a large slug of strictly medicinal whiskey administered by the company’s nurse, along with an immediate cash bonus and a commendation in her file from the president of MM himself had allowed her to continue in her critical fron
